Thrombin Receptor Activator for Peptide 5 (TRAP-5) is also called Coagulation Factor II Receptor (1-5) or Proteinase Activated Receptor 1 (1-5), used in the research of coronary heart disease (CHD).
CAT No: R1715
CAS No: 141685-53-2
Synonyms/Alias: 141685-53-2;H-SER-PHE-LEU-LEU-ARG-OH;Thrombin Receptor Activator for Peptide 5 (TRAP-5);L-Arginine, L-seryl-L-phenylalanyl-L-leucyl-L-leucyl-;TRAP-5 trifluoroacetate salt;(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-hydroxypropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]-5-(diaminomethylideneamino)pentanoic acid;Ser42-Phe-Leu-Leu-Arg46;(2S,5S,8S,11S,14S)-14-Amino-11-benzyl-2-(3-guanidinoPropyl)-15-hydroxy-5,8-diisobutyl-4,7,10,13-tetraoxo-3,6,9,12-tetraazapentadecan-1-oic acid;SFLLR-OH;P5;Ser-Phe-Leu-Leu-Arg;Thrombin Receptor Activator for Peptide 5 TRAP-5;BDBM85088;DTXSID80649491;HY-P1536;AKOS030525615;DA-78585;FT108440;PD099870;H-Ser-Phe-Leu-Leu-Arg-OH; H-SFLLR-OH;CS-0044800;L-Seryl-L-phenylalanyl-L-leucyl-L-leucyl-N~5~-(diaminomethylidene)-L-ornithine;(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-phenylpropanamido]-4-methylpentanamido]-4-methylpentanamido]-5-carbamimidamidopentanoic acid;
Quick InquiryCustom Peptide SynthesisPeptide Library Construction and Screening
Powerful screening tools in biological and chemical research
M.F/Formula | C30H50N8O7 |
M.W/Mr. | 634.8 |
Sequence | One Letter Code:SFLLR Three Letter Code:H-Ser-Phe-Leu-Leu-Arg-OH |
Purity | >98% |
Source# | Synthetic |
Long-term Storage Conditions | Soluble in water |
Shipping Condition | Shipped at room temperature |
InChI | InChI=1S/C30H50N8O7/c1-17(2)13-22(26(41)35-21(29(44)45)11-8-12-34-30(32)33)37-27(42)23(14-18(3)4)38-28(43)24(36-25(40)20(31)16-39)15-19-9-6-5-7-10-19/h5-7,9-10,17-18,20-24,39H,8,11-16,31H2,1-4H3,(H,35,41)(H,36,40)(H,37,42)(H,38,43)(H,44,45)(H4,32,33,34)/t20-,21-,22-,23-,24-/m0/s1 |
InChI Key | LJYDIYITSYDTAY-LSBAASHUSA-N |
Canonical SMILES | CC(C)CC(C(=O)NC(CC(C)C)C(=O)NC(CCCN=C(N)N)C(=O)O)NC(=O)C(CC1=CC=CC=C1)NC(=O)C(CO)N |
Isomeric SMILES | CC(C)C[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CO)N |
2. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes
3. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die
4. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
Required fields are marked with *
×If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at info@creative-peptides.com. We will endeavor to provide highly satisfying products and services.